News
Molbio Diagnostics raises $85 M from Temasek
Molbio will utilise the funds to expand its global network
Singapore-based investment firm Temasek has invested $85 million (around Rs 680 crore) in Goa-based diagnostics chain, Molbio Diagnostics. The company will be valued at $1.6 billion post the round.
The latest fundraising is a combination of primary and secondary market transactions with partial exits by angel investors. Molbio will utilise the funds to expand its global network. Currently, the diagnostics chain operator has a presence in over 40 countries and it plans to further add 20-25 countries every year.
Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.